MOLECULAR BASIS FOR INHIBITION OF DNA REPAIR INITIATION
抑制 DNA 修复启动的分子基础
基本信息
- 批准号:3250173
- 负责人:
- 金额:$ 11.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-08-01 至 1988-11-30
- 项目状态:已结题
- 来源:
- 关键词:Bacillus subtilis DNA DNA repair Escherichia coli O glycosidase acetylaminofluorene cell bank /registry chemical addition conformation covalent bond environmental toxicology enzyme substrate human tissue methylpurine mutagens nonvisual photosensitivity nucleic acid sequence pyrimidine dimers radiation genetics radiotracer ultraviolet radiation uracil xeroderma pigmentosum
项目摘要
Sites of DNA modification by chemical and physical mutagens are repaired by
the excision-repair pathway. This is initiated by DNA glycosylases that
cleave the damaged base at its linkage to the sugar. Two such enzymes,
uracil-DNA glycosylase from B. subtilis and pyrimidine dimer-DNA
glycosylase from T4-infected E. coli are inhibited by the presence of
carcinogen-modified non-substrate guanines in DNA. Left unrepaired, uracil
in DNA is mutagenic and the pyrimidine dimer both mutagenic and
carcinogenic. Therefore carcinogen-modified purines may be mutagenic by
inhibition of excision of those glycosylase-sensitive moieties. The basis
for this interference is undetermined and the mechanism of recognition of
damaged substrates by repair glycosylases is not understood. Therefore the
activities of these two purified DNA repair enzymes acting on human alphoid
sequences containing more than one form of DNA damage will be studied. The
effects of purine adducts of the carcinogens
N-acetoxy-N-2-acetylaminofluorene, N-hydroxy-N-2 acetylaminofluorene,
dimethyl sulfate and 4-nitroquinoline-1-oxide on recognition and incision
of uracil and pyrimidine dimers will be explored. The substrates will be
end-labeled and sites of DNA modification analysed by combining chemical
and enzymic probes to Maxam-Gilbert sequencing techniques. Sites of enzyme
action will be located on these sequencing gels. Sites of enzyme binding
to their damaged substrates will be mapped using the photofootprinting
technique. This method uses protection of DNA pyrimidines from
photochemical damage to demonstrate sites of DNA-protein contacts. The
effects of carcinogen-modified purines on the binding of these repair
glycosylases will be demonstrated on sequencing gels and quantitated by
microdensitometry. The system will be extended to the initiation of
excision-repair of DNA damage in cultured human cells. Because carcinogen
modification of DNA causes transition from the right-handed B-form to the
left-handed Z-form, the enzymic excision of uracil from polymers in these
different conformations will be compared. The molecular bases of any
differences will be explored by sequencing and photo-footprinting methods.
This work will there elucidate the mode of recognition of damaged
substrates by DNA glycosylases, demonstrate the effect of damaged purines
on such binding, and explore the effects of conformational changes on the
repairability of DNA damage.
由化学和物理诱变剂引起的DNA修饰位点由
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUNO CALABRETTA其他文献
BRUNO CALABRETTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUNO CALABRETTA', 18)}}的其他基金
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
淋巴细胞白血病细胞转录重编程的新策略
- 批准号:
10392174 - 财政年份:2022
- 资助金额:
$ 11.16万 - 项目类别:
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
淋巴细胞白血病细胞转录重编程的新策略
- 批准号:
10543999 - 财政年份:2022
- 资助金额:
$ 11.16万 - 项目类别:
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
靶向 Ph 和 Ph1 样急性淋巴细胞白血病 (ALL) 中的 CDK6 表达/活性
- 批准号:
10437005 - 财政年份:2021
- 资助金额:
$ 11.16万 - 项目类别:
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
靶向 Ph 和 Ph1 样急性淋巴细胞白血病 (ALL) 中的 CDK6 表达/活性
- 批准号:
10317798 - 财政年份:2021
- 资助金额:
$ 11.16万 - 项目类别:
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
靶向 Ph 和 Ph1 样急性淋巴细胞白血病 (ALL) 中的 CDK6 表达/活性
- 批准号:
10652495 - 财政年份:2021
- 资助金额:
$ 11.16万 - 项目类别:
The role of chromatin structure in differentiation of hematopoietic stem cells
染色质结构在造血干细胞分化中的作用
- 批准号:
9037410 - 财政年份:2016
- 资助金额:
$ 11.16万 - 项目类别:
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
靶向 CML 干细胞中的 C/EBPalpha-Gfi 通路
- 批准号:
8737206 - 财政年份:2013
- 资助金额:
$ 11.16万 - 项目类别:
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
靶向 CML 干细胞中的 C/EBPalpha-Gfi 通路
- 批准号:
8451043 - 财政年份:2013
- 资助金额:
$ 11.16万 - 项目类别:
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
靶向 CML 干细胞中的 C/EBPalpha-Gfi 通路
- 批准号:
9120811 - 财政年份:2013
- 资助金额:
$ 11.16万 - 项目类别:
TRANSCRIPTION FACTOR REGULATION BY THE BCR/ABL ONCOGENE
BCR/ABL 癌基因对转录因子的调节
- 批准号:
6952413 - 财政年份:2002
- 资助金额:
$ 11.16万 - 项目类别:
相似国自然基金
基于仿生非平衡态的DNA纳米机器构建及其对多种霉菌毒素高灵敏同步
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
复制蛋白A小分子抑制剂-HAMNO调控DNA损伤修复的结构及功能研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于合金@硼烯的比率型折纸电化学芯片构建及其在多种循环肿瘤DNA的超灵敏检测
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于 DNA 编码分子库的新型蛋白抑制剂分子胶水活性评价与机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
HMGCL通过H3K27乙酰化增强RAD52依赖的DNA损伤修复促进宫颈癌放疗抵抗的机制研究
- 批准号:JCZRLH202500546
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
替尼泊苷抑制APEX1驱动DNA损伤在治疗肺癌中的作用及机制研究
- 批准号:JCZRYB202500477
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
NEDD4泛素化调控CREB/miR-132轴诱发精子DNA碎片化在肥胖不育中的作用及机制
- 批准号:QN25H200016
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
高强度DNA杂化纳米机器人在内体膜调控和核酸药物递送中的基础研究
- 批准号:HDMZ25H300006
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
PLOD2的DNA低甲基化模式驱动内质网与线粒体代谢串扰诱导免疫微环境重塑和化疗耐药
- 批准号:KLY25H160008
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
LncRNA SNHG14调控miR-214-3p的DNA甲基化水平在支气管肺发育不良肺泡化阻滞的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 11.16万 - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
$ 11.16万 - 项目类别:
Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 11.16万 - 项目类别: